ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $376,630 | -75.3% | 236,874 | -3.3% | 0.00% | – |
| Q4 2022 | $1,526,812 | -16.9% | 245,074 | -10.7% | 0.00% | – |
| Q3 2022 | $1,838,000 | -1.3% | 274,425 | -6.3% | 0.00% | – |
| Q2 2022 | $1,862,000 | +37.1% | 292,778 | 0.0% | 0.00% | – |
| Q1 2022 | $1,358,000 | +24.4% | 292,778 | +34.1% | 0.00% | – |
| Q4 2021 | $1,092,000 | +70.1% | 218,320 | +1926.5% | 0.00% | – |
| Q4 2019 | $642,000 | -9.8% | 10,773 | -29.6% | 0.00% | – |
| Q2 2019 | $712,000 | +16.0% | 15,296 | 0.0% | 0.00% | – |
| Q1 2019 | $614,000 | -25.8% | 15,296 | -14.9% | 0.00% | – |
| Q4 2018 | $827,000 | +63.1% | 17,979 | +39.0% | 0.00% | – |
| Q2 2018 | $507,000 | -90.8% | 12,935 | -83.0% | 0.00% | -100.0% |
| Q1 2018 | $5,488,000 | +198.1% | 75,869 | +171.3% | 0.00% | – |
| Q4 2017 | $1,841,000 | +17.9% | 27,961 | -10.3% | 0.00% | – |
| Q3 2017 | $1,562,000 | +302.6% | 31,159 | +272.0% | 0.00% | – |
| Q2 2017 | $388,000 | +53.4% | 8,376 | +206.8% | 0.00% | – |
| Q1 2015 | $253,000 | – | 2,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |